Jazz Pharmaceuticals, INC.

Specialty pharmaceuticals

Based in CA

🤖

AI Overview

With $2.0M in lobbying spend across 29 quarterly filings, Jazz Pharmaceuticals, INC. is a significant lobbying presence.

$2.0M

Total Lobbying Spend

Quarterly Filings

Lobbying Firms Used

Individual Lobbyists

Spending by Year

Year	Lobbying Spend
2018	$180K
2019	$200K
2020	$320K
2021	$320K
2022	$320K
2023	$320K
2024	$200K
2025	$150K

Lobbying Firms

AVENUE SOLUTIONS

What They Lobby For

PL 114-255, 21st Century Cures Act, implementation; H.R. 4784, Lower Drug Costs Through Competition Act; S. 974/H.R. 2212, CREATES Act of 2015; H.R. 2051, FAST Generics; Drug safety issues; Prescription drug abuse; Issues related to opioids policies and offsets; H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018); S. 2680, Opioid Crisis Response Act of 2018
Drug safety issues; Prescription drug abuse; Issues related to opioids policies and offsets; H.R. 965/ S. 340, CREATES Act of 2019
Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; H.R. 965/ S. 340, CREATES Act of 2019; S. 1416, Affordable Prescriptions for Patients Act of 2019
Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; H.R. 965/ S. 340, CREATES Act of 2019; S. 1416, Affordable Prescriptions for Patients Act of 2019; H.R. 1865, Consolidated Domestic and International Assistance Bill; H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; S. 1416, Affordable Prescriptions for Patients Act of 2019; H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; H.R. 748 (Public Law 116-136), CARES Act
Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; S. 1416, Affordable Prescriptions for Patients Act of 2019; H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; Public Law 116-136, CARES Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA)
Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; S. 1416, Affordable Prescriptions for Patients Act of 2019; H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; Public Law 116-136, CARES Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA); Issues related to Priority Review Voucher extension; H.R. 6800, The Heroes Act; H.R. 925, The Heroes Act
Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; S. 1416, Affordable Prescriptions for Patients Act of 2019; H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; Public Law 116-136, CARES Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA); Issues related to Priority Review Voucher extension; H.R. 6800, The Heroes Act; H.R. 925, The Heroes Act; H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)
Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; Continue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress ; Continue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; Continue monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Continue monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress Continue monitoring Consolidated Appropriations Act, 2021 (PL 116-260); H.R. 1319, American Rescue Plan Act of 2021 (PL 117-2)
Drug safety issues; Monitor drug pricing legislation; Continue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress; Continue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; Continue monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Continue monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress; Senate Finance Committee Prescription Drug Pricing Reform Principles; Implementation of American Rescue Plan Act of 2021 (PL 117-2)